<DOC>
	<DOCNO>NCT01660945</DOCNO>
	<brief_summary>The investigator hypothesize vytorin may improve vascular insulin resistance hypercholesterolemic patient</brief_summary>
	<brief_title>Vascular Metabolic Effects Vytorin</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Ezetimibe , Simvastatin Drug Combination</mesh_term>
	<criteria>hypercholesterolemia overt liver disease , chronic renal failure , hypothyroidism , myopathy , uncontrolled diabetes ( HbA1c &gt; 9 % ) , severe hypertension , stroke , acute coronary event , coronary revascularization within precede 3 month , alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>statin , insulin resistance</keyword>
</DOC>